ARWR
Arrowhead Pharmaceuticals Inc
68.80$
+3.5%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +118.3% | -58.6% | +19,736.5% | -48.6% | +945.7% | -47.9% | +57.2% | +75.9% | -1.0% | -98.5% | +23,258.2% | |
| – | +2,052.8% | +0.6% | -22.7% | +5.8% | – | – | – | – | +19.9% | +48.8% | +28.7% | |
| – | – | -58.6% | +19,736.5% | -48.6% | +945.7% | -47.9% | +57.2% | +75.9% | -6.2% | -106.6% | – | |
| – | +104.3% | -12.3% | +11.6% | +4.4% | +58.7% | +61.2% | +67.0% | +44.1% | +15.1% | +42.9% | +24.1% | |
| – | +42.2% | -32.0% | -25.8% | +9.2% | +39.0% | +96.9% | +54.9% | +53.7% | -26.9% | +6.5% | +25.9% | |
| – | +72.7% | +0.6% | -22.7% | +5.8% | +53.1% | +69.8% | +64.0% | +46.8% | +2.7% | +35.3% | +24.8% | |
| – | – | – | – | – | – | -252.2% | – | – | – | – | – | |
| – | +13.0% | -63.5% | +56.2% | +152.6% | +563.6% | +32.1% | -99.9% | -17.8% | +264.1% | +76.5% | +176.2% | |
| – | – | – | – | – | – | -224.1% | – | – | – | – | – | |
| – | -54.7% | +0.0% | +0.0% | +0.0% | +7,150.0% | -98.9% | +0.0% | +189,150.0% | -26.4% | -199.4% | – | |
| – | – | – | – | – | – | -224.4% | – | – | – | – | – | |
| – | – | – | – | – | – | -232.9% | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.